Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-gvh9x Total loading time: 0 Render date: 2024-07-17T12:16:33.406Z Has data issue: false hasContentIssue false

36 - Phosphatidylinositol pathways

from Part IV - Signal transduction/biochemical aspects

Published online by Cambridge University Press:  10 December 2009

William M. Pardridge
Affiliation:
University of California, Los Angeles, School of Medicine
Get access

Summary

General considerations concerning the phosphatidylinositol cycle

The discovery of the ‘phosphoinositide effect’ by Hokin and Hokin as early as in 1953 (Hokin and Hokin, 1953) demonstrating that acetylcholine could stimulate the incorporation of 32Pi into phosphatidylinositol (PI) and phosphatidic acid (PA), revealed the association between hormone action and phospholipid turnover. Later, the agonistinduced phosphoinositide turnover and its relationship to Ca2+ signaling were described (Michell, 1975). The fact that the hydrolysis of phosphatidylinositol bisphosphate (PIP2) by a phosphoinositide – specific phospholipase C yields two second messengers: 1,2-diacylglycerol (DAG), which activates protein kinase C and inositol 1,4,5-trisphosphate (IP3) which mobilizes Ca2+ from intracellular stores, was demonstrated (Streb et al., 1983).

Although reported some years ago, this phosphoinositide field is currently one of the most interesting fields in biochemistry, which has witnessed during the past decade a tremendous increase in the knowledge of the PI pathway. To gain more insights into this field the following roles are studied: the nuclear metabolism of the PI cycle, the role of phosphatases and the role of higher phosphorylated forms as IP4, IP5 and IP6 (Heslop et al., 1985; Malviya et al., 1990; Henzi and McDermott, 1992). In this regard, phosphoinositide-mediated signal transduction in the nervous system is no exception, and a general view of the PI pathway is now available (Fisher et al., 1992).

Type
Chapter
Information
Introduction to the Blood-Brain Barrier
Methodology, Biology and Pathology
, pp. 330 - 337
Publisher: Cambridge University Press
Print publication year: 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×